- Current Treatment Options for Multiple Sclerosis

 – August 31, 2012  –– 

Multiple sclerosis (MS) is an autoimmune disease that affects approximately 400,000 people in the United States.  Caused by damage to the myelin sheath – the protective coating of the nerves in the brain – MS is marked by an array of symptoms, including muscle spasms, loss of vision and difficulty moving arms and legs. A recent study published in the Journal of Neuroscience, revealed the potential for a ‘one-size-fits-all’ drug that could treat not just MS, but Alzheimer’s, brain injury, and other neurological disorders as well.  “Our next big expansion is oral medications,” said Dr. Fred Lublin from Mount Sinai School of Medicine. “Much of what we use is injectable.  We have one pill that is available now.  We have two more pills that are in the hands of the FDA that we should be hearing about very soon.  And the pills are very effective and will be a nice substitute for injections.”
- Dr. Fred Lublin, Professor, Neurology, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, The Mount Sinai Medical Center

Learn more